SheMed: Funding, Investors & Team (Sep 2026)
SheMed is revolutionizing women's healthcare with tailored test-to-treat solutions that are both easy to access and personalized for women.
SheMed has raised $50.0M across 1 funding round on record, the most recent a Series A of $50.0M announced in Oct 2025.
That round is above the $2.2M median round size for Health and Human Services companies tracked on FundedIQ over the last two years.
SheMed Company Profile and Key Stats
Latest funding round on record: Oct 2025.
SheMed Funding Rounds
SheMed Founders and Leadership Team
No contact details are on record for this team yet.
SheMed Funding Compared to Other Health and Human Services Startups
SheMed's latest round of $50.0M is above the median round in Health and Human Services. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like SheMed in Health and Human Services and London
Companies Similar to SheMed
Turning audible sound into health insights using AI
Alderley Lighthouse Labs, located at Alderley Park, is a provider of pathology services that has been…
Onto Health offers a suite of fertility and reproductive health services delivered through technology-enabled…
Move To Happiness offers a platform designed to help companies implement and manage ESG (Environmental,…
PREVE's primary focus appears to be improving the physiotherapy experience with the use of technology. By…
VRelax offers scientifically-supported VR settings and activities designed to assist individuals dealing with…
Zivian Health is an administrative platform that assists healthcare organizations in locating highly skilled…
RFC Power develops grid-scale long-duration energy storage technology for renewable power systems.
RT BIO SYSTEMS specializes in biotechnological research, manufacture, and B2B supply of health supplements…
Breedr is a productivity and marketing platform that’s transforming the livestock supply-chain.
TRIVER offers immediate funding to small businesses with just a single click. By utilizing Open Banking data…
Itoflow is an AI-native platform providing institutional-grade, automated quantitative research and portfolio…
SheMed Funding FAQs
What does SheMed do?
SheMed is revolutionizing women's healthcare with tailored test-to-treat solutions that are both easy to access and personalized for women.
How much funding has SheMed raised?
SheMed has raised $50.0M across 1 round on record. The most recent is a Series A of $50.0M announced in Oct 2025.
When did SheMed last raise funding?
SheMed's most recent funding round on record is a Series A of $50.0M, announced in Oct 2025.
Who founded SheMed?
FundedIQ lists Olivia Ferro (Founder) at SheMed.
Where is SheMed headquartered?
SheMed is based in London, England, United Kingdom.
How many employees does SheMed have?
SheMed is in the 11-50 employee band.
How does SheMed's funding compare to other Health and Human Services startups?
SheMed's latest round of $50.0M is above the $2.2M median round size for Health and Human Services companies on FundedIQ across 8 tracked companies over the last two years.
About FundedIQ's SheMed Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for SheMed is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.